Skip Navigation
Print This Page
Share this page: More

Developing Clinical Rating Scales

Quantifying disability in multiple sclerosis (MS) is important in clinical trials as a measurement of drug effect. However, the current rating scales are thought to be insensitive to the changes that occur over time in MS. We are using quantitative measures of strength and sensation to determine if this approach may be better than the usual clinical rating scales called Expanded Status Disability Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC).

We have been able to demonstrate that quantitative assessments of spinal cord function, in MS patients, such as vibration perception thresholds, can give us more specific neurological information. This information may be vital to evaluate the efficacy of future therapies or rehabilitation programs. Collaborators include Drs. Kathy Zackowski, Scott Newsome and Peter Calabresi.


Related Links

Attacking Two Brain Disorders on Multiple Fronts
Uncover how Hopkins researchers are finding new treatments and diagnostic tools to treat multiple sclerosis and transverse myelitis.

Looking Forward

Read the latest issue of our newsletter

Looking Forward Fall 2014 cover

Previous Issues

Out-of-State and International Patients - Find Out More


© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.